Lipovite (MIC + B12) Information & Coordination for Licensed U.S. Clinics
Lipovite (MIC + B12) is presented on this page as a multi-ingredient compounded preparation. Because MIC + B12 formulations can vary, clinic teams should confirm the complete ingredient list, ingredient forms, concentrations, and labeling for the specific preparation under review.
Phoenix Meds Inc. supports licensed U.S. healthcare organizations with clinic verification, documentation organization, publicly available regulatory information, and administrative pharmacy coordination.
Because compounded multi-ingredient preparations can vary, clinic teams should review the exact formulation, ingredient forms, labeling, pharmacy documentation, and regulatory information associated with the preparation under consideration.
What Licensed Clinics Should Know About Lipovite
“Lipovite” or “MIC + B12” does not by itself identify a standardized drug formulation.
Different preparations may contain different ingredient forms, concentrations, additional vitamins, or other components. For professional review, the actual formulation should therefore be identified from the product and pharmacy documentation rather than inferred from the name alone. Relevant details may include:
- the complete ingredient list;
- the specific form of vitamin B12;
- concentration of each ingredient;
- vial presentation and labeling;
- dispensing or compounding pharmacy information; and
- supporting product documentation.
This distinction is particularly important for compounded preparations because the regulatory considerations may differ among individual ingredients.
For details about other medication information and coordination, see medication information resource page.
Current FDA and Compounding Status
The FDA sources reviewed for this page do not identify Lipovite as an FDA-approved finished drug product.
FDA states that compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality in the same manner as FDA-approved drug products.
For a multi-ingredient MIC + B12 preparation, regulatory considerations can depend on the exact bulk drug substances used.
FDA’s May 14, 2026 section 503A nomination document lists choline chloride and methylcobalamin in Category 1 among bulk drug substances under evaluation.
The same FDA document lists choline bitartrate separately in Category 3 among substances nominated without adequate supporting information for FDA to evaluate them.
Category 1 status is not FDA approval or final inclusion on the 503A Bulks List. FDA also makes clear that its Category 1 interim policy applies only when the conditions described in the agency’s guidance are met.
These categories apply to specific bulk drug substances; they do not establish FDA approval or a single regulatory status for a multi-ingredient preparation marketed as Lipovite or MIC + B12.
For clinic teams, the exact formulation and ingredient forms should therefore be confirmed from the preparation’s labeling and supporting documentation.
How Phoenix Meds Supports Lipovite Inquiries
A Lipovite-related inquiry may involve clinic credentials, formulation records, ingredient information, pharmacy documentation, labeling, and questions about the current regulatory record. Phoenix Meds helps keep those administrative pieces organized. Our support may include:
- clinic and provider credential verification
- organization of available formulation and ingredient documentation
- review of pharmacy-provided labeling and supporting records
- access to publicly available FDA and licensing information
- administrative pharmacy coordination; and
- documentation follow-up when additional records are needed.
This gives clinic teams a clearer administrative record while formulation, compounding, dispensing, prescribing, and product-specific regulatory decisions remain with the licensed parties responsible for them.
Documentation and Due Diligence
For a multi-ingredient formulation, documentation is especially important because the product name alone may not describe the complete preparation. Clinic teams may need to review:
- the full formulation and ingredient forms
- concentration of each component
- the form of vitamin B12 used
- labeling
- pharmacy or facility information
- available lot or batch records
- certificates of analysis or other pharmacy-provided documents, when available; and
- relevant FDA or licensing information
Phoenix Meds can organize available records for professional review and flag documentation that may require follow-up.
We do not independently test or certify identity, purity, potency, sterility, stability, safety, effectiveness, or regulatory compliance.
Lipovite Administrative Coordination for Licensed Clinics
Our coordination services are available to licensed medical clinics only. Authorized pharmacies remains responsible for its own formulation, compounding, dispensing, product-specific, and regulatory decisions.
Clinic Verification
Documentation Review
Pharmacy Coordination
Where appropriate, Phoenix Meds can support administrative pharmacy coordination concerning documentation between a verified licensed clinic and an independent licensed pharmacy.
Frequently Asked Questions
Is Lipovite FDA-approved?
The FDA sources reviewed for this page do not identify Lipovite as an FDA-approved finished drug product. FDA states that compounded drugs are not FDA-approved.
Is every Lipovite or MIC + B12 formulation the same?
No. Multi-ingredient compounded formulations may vary in ingredient forms, concentrations, and additional components. Clinics should review the formulation and labeling associated with the specific preparation.
What is the FDA context for ingredients used in MIC + B12 formulations?
Regulatory considerations depend on the exact ingredients. FDA’s current section 503A materials list choline chloride and methylcobalamin in Category 1 as bulk drug substances under evaluation. Category 1 is not FDA approval or final inclusion on the 503A Bulks List.
What can Phoenix Meds help my clinic with?
Can Phoenix Meds help organize a COA or batch documentation?
Yes, when those records are supplied by another party. Phoenix Meds does not independently verify or certify the underlying testing results.
Does Phoenix Meds dispense or ship Lipovite?
No. Phoenix Meds does not manufacture, compound, prescribe, dispense, sell, ship, test, or take custody of medications. Those activities remain with the appropriately licensed entities responsible for performing them.
Important Notice
Phoenix Meds Inc. provides administrative coordination and documentation support for licensed U.S. healthcare organizations.
We are not a pharmacy, medical practice, manufacturer, wholesaler, distributor, prescriber, or dispensing entity.
Information on this page is provided for professional and administrative purposes and does not constitute medical or legal advice, FDA approval, a prescribing recommendation, or a product-specific regulatory determination.